Metabolic Syndrome: all 2,011 studies

Page 20 of 21. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome ObesityStatus unknownNCT00408850Phase 3
• Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)Status unknownNCT00408824
• MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance StudyCompletedNCT00405197Not applicable
• The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.CompletedNCT00405015Phase 2
• Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic SyndromeCompletedNCT00403689Not applicable
• Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance ImagingCompletedNCT00401336Not applicable
• The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) StudyCompletedNCT00400231Phase 2
• Evaluation of Effect of Exercise on PrescriptionStatus unknownNCT00399997Phase 2/3
• Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic SyndromeStatus unknownNCT00399932
• Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic SyndromeCompletedNCT00394745Phase 3
• Diet, Obesity and Genes (DiOGenes)CompletedNCT00390637Phase 4
• Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic SyndromeCompletedNCT00385658Phase 4
• Testosterone Effects on Men With the Metabolic SyndromeWithdrawnNCT00382057Phase 2
• Milk Types and Fish Oil in 9- to 12-Month-Old InfantsCompletedNCT00379171Not applicable
• The Effect of Milk and Meat on IGFs in Prepubertal BoysCompletedNCT00378859Not applicable
• The Effect of Whey and Casein on IGFs in Prepubertal BoysStatus unknownNCT00378820Not applicable
• 11ß-HSD1 and Metabolic SyndromeCompletedNCT00370305Phase 2
• Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic SyndromeCompletedNCT00364221Phase 4
• Side Effects of Antipsychotic MedicationsCompletedNCT00363181
• Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic SyndromeCompletedNCT00362908Not applicable
• Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.CompletedNCT00356785Not applicable
• Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic AdultsCompletedNCT00352287Phase 4
• The Effects of Omega-3 Fatty Acids on Metabolic SyndromeStatus unknownNCT00350194Early Phase 1
• Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic SyndromeStatus unknownNCT00350064Not applicable
• A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic SyndromeCompletedNCT00349284Phase 3
• The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)CompletedNCT00346970Phase 4
• Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study CohortCompletedNCT00344903
• Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory PartnershipCompletedNCT00336869
• Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic SyndromeCompletedNCT00335699Phase 4
• Effectiveness of Nigella Sativa (Kalonji) Seed in DyslipidemiaCompletedNCT00327054Phase 1/2
• A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) MetabolismCompletedNCT00327002Phase 2
• The Effects of Cilnidipine on Metabolic Syndrome ImprovementCompletedNCT00325936Phase 4
• Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young AdultsCompletedNCT00318734
• Health of Young European Families and Fish ConsumptionStatus unknownNCT00315770Phase 1
• The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic SyndromeCompletedNCT00314561Phase 4
• The Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban CityStatus unknownNCT00308672
• Effect of Growth Hormone in Metabolic SyndromeStatus unknownNCT00307411Phase 4
• Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 DiabetesCompletedNCT00306644Phase 4
• Study of Niacin and Rosiglitazone in Dysmetabolic DyslipidemiaCompletedNCT00304993Phase 4
• VIsceral Fat Reduction Assessed by CT-scan On RImonabAntCompletedNCT00299325Phase 3
• Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE)CompletedNCT00298428Not applicable
• The Effect of Diet and Exercise in Heart FailureCompletedNCT00297154Not applicable
• PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic SyndromeCompletedNCT00296803Phase 4
• Collaborative Care for Heart Failure Patients With the Metabolic SyndromeCompletedNCT00293852Not applicable
• Study of How Exercise or Weight Loss Effects Metabolic SyndromeStatus unknownNCT00292994Not applicable
• Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid MetabolismCompletedNCT00287820Phase 4
• Integrating the Genetic and Metabolic Faces of ObesityCompletedNCT00285844Phase 1
• The Incidence and Treatment of Insulin Resistance Among Men With Erectile DysfunctionCompletedNCT00284960
• Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric SyndromeTerminatedNCT00283374
• Effects of Resistance and Aerobic Exercise on Cardiovascular HealthCompletedNCT00275145Phase 2
• Lifestyle Intervention in Obese Arab WomenCompletedNCT00273572Not applicable
• Does Metabolic Syndrome Exist in Anorexia Nervosa?CompletedNCT00271921
• The Metabolic Effects of Almond Consumption in Adults With Pre-DiabetesCompletedNCT00270985Phase 1
• Comparison of Two Different Diets on Health OutcomesStatus unknownNCT00269646Not applicable
• The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk FactorsStatus unknownNCT00266292Not applicable
• Study In Patients With DyslipidaemiaCompletedNCT00264667Phase 2
• Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and ObesityTerminatedNCT00261898Phase 2
• Efficacy of Topiramate for Weight Loss in Subjects With Metabolic SyndromeSuspendedNCT00243984Phase 3
• Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma ActivitiesCompletedNCT00242814Phase 4
• Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic SyndromeCompletedNCT00241150Phase 4
• A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic SyndromeCompletedNCT00240305Phase 3
• Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)CompletedNCT00240266Phase 3
• Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)CompletedNCT00234858Phase 4
• A Study of the Function of Hormones Present In Taste BudsCompletedNCT00233298
• Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Diet Compared With a Standard DietCompletedNCT00230919Not applicable
• Comparison of 4 Diets in the Management of Overweight Patients With Vascular DiseaseTerminatedNCT00229229Phase 4
• Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on RimonabantTerminatedNCT00228176Phase 3
• Rosiglitazone Versus Placebo in Chronic Stable AnginaTerminatedNCT00225355Phase 4
• The Effects of Aripiprazole on Patients With Metabolic SyndromeCompletedNCT00224822Phase 4
• Effective Endurance Training in Metabolic SyndromeCompletedNCT00218998Not applicable
• Exercise and Flax-Based Nutritional Supplementation for Lowering CholesterolCompletedNCT00204412Phase 3
• Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)Status unknownNCT00201292
• Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I)CompletedNCT00200993Phase 2
• Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese PersonsCompletedNCT00194428Phase 1/2
• Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial FunctionCompletedNCT00189085Phase 4
• Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin SecretionCompletedNCT00188773Phase 4
• A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to InsulinCompletedNCT00185094Phase 4
• The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty AcidsCompletedNCT00184899Not applicable
• Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative StressStatus unknownNCT00177892Not applicable
• Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory MarkersCompletedNCT00175084Not applicable
• Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory MarkersCompletedNCT00175071Not applicable
• Metabolic Syndrome and Insulin Resistance in Primary AldosteronismStatus unknownNCT00173082
• Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-DiabetesStatus unknownNCT00172796
• The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy BalanceStatus unknownNCT00172614
• Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome PatientsCompletedNCT00171548
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic SyndromeCompletedNCT00170937Phase 4
• Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle InterventionsStatus unknownNCT00163943Not applicable
• Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)CompletedNCT00157924Phase 4
• MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)CompletedNCT00157729Phase 2
• Odense Androgen Study in the ElderlyCompletedNCT00155961
• Telmisartan-Induced Reduction in Intra-Myocellular Lipids TrialCompletedNCT00147264Phase 3
• Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes MellitusCompletedNCT00145093Phase 3
• Dairy Products and Metabolic Effects (Norwegian Part)CompletedNCT00140816Not applicable
• Other Effects of Fluvastatin Are Investigated in Patients With Metabolic SyndromeCompletedNCT00138528Phase 4
• Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic SyndromeCompletedNCT00129792Not applicable
• Chromium Picolinate for the Treatment of Metabolic SyndromeCompletedNCT00128154Not applicable
• Exercise and Weight Loss for Improving Mobility in Older Adults Who Are ObeseCompletedNCT00119795Not applicable
• Inflammatory Profiles of Children at High Risk for AtherosclerosisCompletedNCT00115232
• Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic SyndromeCompletedNCT00111956Phase 2/3
• Irbesartan in the Treatment of Hypertensive Patients With Metabolic SyndromeCompletedNCT00110422Phase 4

← Metabolic Syndrome overview